Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study

Excessive activation of the mineralocorticoid receptor (MR) underlies the pathophysiology of heart failure and chronic kidney disease. Hyperkalemia risk limits the therapeutic use of conventional MR antagonists. AZD9977 is a nonsteroidal, selective MR modulator that may protect nonepithelial tissues...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew Whittaker (Author), Åsa M. Kragh (Author), Judith Hartleib‐Geschwindner (Author), Muna Albayaty (Author), Anna Backlund (Author), Peter J. Greasley (Author), Maria Heijer (Author), Magnus Kjaer (Author), Pablo Forte (Author), Robert Unwin (Author), Linda Wernevik (Author), Hans Ericsson (Author)
Format: Book
Published: Wiley, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available